Rights Issue Offer - Optionholder Letter
Released
Released
Announcement PDF
19 October 2023
Dear Optionholder
Non-Renounceable Rights Issue Offer
On 16 October 2023, HITIQ Limited ACN 609 543 213 (Company) announced that it is
undertaking a non-renounceable pro-rata entitlement offer of 1 new Share (New Share) for every
2 Shares held at the Record Date of 7.00pm on 24 October 2023 (Record Date), at an Issue Price
of $0.022 (2.2 cents) per New Share (Entitlement), plus 1 New Option to purchase 1 Share for
every 2 New Share issued under the Offer (collectively, Rights Issue Offer) to raise a up to
approximately $3.23 million (before costs), the maximum being on the basis that no more than
approximately 147,031,768 New Shares will be issued pursuant to the Rights Issue Offer. The
Rights Issue Offer is not underwritten.
Shareholders who subscribe for their full Entitlement will also be able to subscribe for Additional
Shares at the same price, and will also be issued 1 New Option for every 2 Additional Share issued
to them (Top-Up Offer). The Company not be applying to list the New Options on the ASX as an
additional quoted class of securities in the Company.
The Directors have reserved the right for up to 3 months after the close of the Rights Issue Offers
to place any shortfall under the Rights Issue Offers (if any) (Shortfall) at a price no less than the
Issue Price (Shortfall Offer).
The Rights Issue Offer, Top-Up Offer and Shortfall Offer are being made pursuant to a prospectus
dated 19 October 2023 issued in accordance Section 713 of the Corporations Act 2001 (Offers
Prospectus). A copy of the above announcement, together with further details of the Offers, are
available on the Company's website (www.hitiq.com) and also on the ASX Announcement Platform.
You are the holder of unlisted options to purchase Shares in the Company. The Rights Issue Offer
is only available to holders of Shares in the Company, and not with respect to Shares that underly
any options that have not been exercised. This letter is not an offer of securities in the Company.
The purpose of this letter is to advise you that you are not entitled to participate in the Rights Issue
Offer (with respect to any Shares that underly your options) without first exercising some or all of
your options. The exercise of your options needs to be completed before the Record Date.
If you decide to exercise some or all of your options before the Record Date, the Shares that issue
upon that exercise of those options will be included in your shareholding as at the Record Date.
Your aggregate holding of Shares at the Record Date determines the extent of your entitlement to
participate in the Rights Issue Offer.
If you do not wish to participate in the Rights Issue Offer (with respect to any Shares that underly
your options), you need take no action in relation to your options.
The anticipated timetable for the Rights Issue Offer is as set out below. The timetable is indicative
only and subject to change. Subject to the Corporations Act 2001 and the ASX Listing Rules, the
Directors reserve the right to vary these dates, including the Closing Date. The Directors also
reserve the right not to proceed with the Rights Issue Offer (or any part of it) at any time prior to
allotment. In that event, any application money received under the Rights Issue Offer will be
returned without interest.
The particulars of the Rights Issue Offer are contained in the announcement made on 16 October
2023. A copy of the Rights Issue Prospectus was lodged with the Australian Securities and
Investments Commission (ASIC) and the ASX on 19 October 2023 and is available for viewing on
the ASX website, ASIC website and the Company's website (www.hitiq.com). The Prospectus and
the Entitlement and Acceptance Form, or access thereto, are expected to be sent to all eligible
Shareholders on the same day.
Please ensure you read the Prospectus in its entirety and refer to the Company’s ASX
announcements before considering whether to participate in the Offer. If in any doubt you should
consult your professional advisor.
For further information on your Entitlement please contact the Company’s share registry, Automic
Registry Services Pty Ltd, on 1300 288 664 (within Australia) or +61 2 9698 5414 (outside Australia)
between 8:30am and 5:00pm AEDT (Australian Eastern Daylight Time).
Yours faithfully,
James Barrie
Company Secretary
About HITIQ
HITIQ Limited (ASX: HIQ) operates in the healthcare equipment sector, providing and further developing a
transformative, end-to-end concussion management technology platform. This platform aims to provide a total
concussion ecosystem whereby the Company’s products support the identification, monitoring, and management of
sport related brain injury. HITIQ’s product suite utilises high-end technology that will span multiple domains – from
early detection and surveillance to assessment and rehabilitation technology tools.
Share your feedback
Discover